Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans

Biol Psychiatry. 1998 Dec 1;44(11):1171-7. doi: 10.1016/s0006-3223(97)00454-x.

Abstract

Background: Behavioral sensitization is the process whereby intermittent stimulant exposure produces a time-dependent, enduring, and progressive behavioral response. Although animal models of sensitization are well established, the phenomenon has been relatively little studied in humans. In a previous study, we reported enhanced responses following a second as compared to a first amphetamine dose in eye-blink rate and ratings of increased motor activity/energy, increased speech, and elevated mood in normal human volunteers. This current study extends those findings in a new sample of normal volunteers.

Methods: Eleven normal human volunteers were administered three single oral doses of d-amphetamine (0.25 mg/kg) at 48-hour intervals, alternating with matched placebo in a randomized, double-blind trial. Hourly behavioral ratings included eye-blink rate, symptoms (elevated mood, increased speech, increased motor activity/energy), and subjective drug effects.

Results: Eye-blink rate and increased motor activity/energy ratings progressively increased following each challenge with the third amphetamine dose response significantly greater than all other conditions 4 hours postadministration. Similar, although less pronounced, responses were observed for elevated mood and subjective drug effect.

Conclusions: These results provide further evidence for sensitization of some amphetamine-induced behaviors in human subjects.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Affect / drug effects*
  • Blinking / drug effects*
  • Dextroamphetamine / pharmacology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psychomotor Performance / drug effects*
  • Speech / drug effects*

Substances

  • Dextroamphetamine